PlusCBD™ Oil Roll-On Launch at 945 Kroger shops in 17 U.S. States
LAS VEGAS, June 12, 2019 (WORLD NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a supplier that is preeminent maker of hemp CBD products, is very happy to announce further expansion of its industry-dominating PlusCBD™ Oil brand utilizing the Kroger Co. (NYSE:KR).
The Company’s expanded distribution that is retail the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across several of its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths areas in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and additional Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant components, warming camphor and cooling menthol. Made out of its Gold Formula focused complete range hemp extract, the Roll-Ons offer high strength help in a application that is easy-to-use. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms can also be found at the participating Kroger areas. All PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and are made without artificial dyes or scents to meet consumer expectations of clean ingredients.
As discussed regarding the Company’s very first quarter 2019 profits turn to May 8, 2019, CV Sciences’ recent circulation gains consist of accessibility to PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy stores. By the addition of 945 Kroger places and new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are for sale in 4,591 retail stores, up from 3,308 stores at the time of March 31, 2019, a growth of 38.7% within the previous two months.
“We are pleased to partner with Kroger and launch our Roll-On that is new topical we carry on our quick expansion to the FDM channel,” said Joseph Dowling, ceo. “Kroger, CVS Pharmacy, and other leading nationwide retailers are keenly conscious of the increased consumer need for hemp-based CBD items and they’re partnering with CV Sciences as a result of our unwavering dedication to safety and quality. We have been at the beginning of everything we believe will undoubtedly be broad acceptance of CBD products across national FDM reports so we look ahead to our continued development even as we expand store count and SKUs with your retail lovers.”
PlusCBD™ Oil Extra Strength Balm ranks #1 in sales both in the Total U.S. Natural Channel and complete U.S. MULO cbd full spectrum tincture (Multi Outlet) over the past 52 months* among CBD services and products within Topical Analgesics, relating to SPINS and IRI data, correspondingly. Brightfield Group, a number one predictive analytics and general market trends company when it comes to CBD market, expects $1.3 billion in product product sales of CBD topicals in 2019, with a substance growth that is annual of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) runs two business that is distinct: a customer item unit centered on production, advertising and attempting to sell plant-based CBD items to a selection of market sectors; and a drug development unit focused on developing and commercializing CBD-based novel therapeutics using CBD. The Company’s PlusCBD™ Oil may be the brand that is top-selling of CBD available on the market, according to SPINS, the key provider of syndicated information and insights for the normal, natural and specialty items industry. CV Sciences, Inc. has offices that are primary facilities in north park, Ca and Las vegas, nevada, Nevada. Extra information can be acquired from OTCMarkets.com or by visiting www.cvsciences.com.
This news release may contain particular forward-looking statements and information, as defined inside the meaning of Section 27A of this Securities Act of 1933 and Section 21E associated with the Securities Exchange Act of 1934, and it is susceptible to the Safe Harbor produced by those parts. This product contains statements about anticipated future occasions and/or financial outcomes which can be forward-looking in general and susceptible to risks and uncertainties. Such statements that are forward-looking meaning involve dangers, uncertainties.